Aquestive Therapeutics, Inc.AQ.STNASDAQ
Loading
Asset Growth Recovery in ProgressRecovering
Percentile Rank33
3Y CAGR-50.6%
Year-over-Year Change
Year-over-year total asset growth rate
3Y CAGR
-50.6%/yr
vs +153.6%/yr prior
Acceleration
-204.2pp
Decelerating
Percentile
P33
Within normal range
vs 3Y Ago
0.1x
Contraction
Streak
1 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q4 2025 | 0.70% |
| Q3 2025 | -0.32% |
| Q2 2025 | 2.26% |
| Q1 2025 | 2.50% |
| Q4 2024 | 1.53% |
| Q3 2024 | 1.30% |
| Q2 2024 | 0.28% |
| Q1 2024 | 6.83% |
| Q4 2023 | -3.25% |
| Q3 2023 | -2.22% |
| Q2 2023 | 2.86% |
| Q1 2023 | 7.38% |
| Q4 2022 | 5.79% |
| Q3 2022 | 4.39% |
| Q2 2022 | 4.98% |
| Q1 2022 | 4.70% |
| Q4 2021 | 2.67% |
| Q3 2021 | 6.91% |
| Q2 2021 | 2.03% |
| Q1 2021 | 8.58% |
| Q4 2020 | -1.10% |
| Q3 2020 | 2.34% |
| Q2 2020 | -6.03% |
| Q1 2020 | 5.47% |
| Q4 2019 | -3.28% |
| Q3 2019 | 0.28% |
| Q2 2019 | 13.76% |
| Q1 2019 | 12.64% |
| Q4 2018 | -0.15% |
| Q3 2018 | -4.85% |
| Q2 2018 | 12.35% |
| Q1 2018 | 8.47% |
| Q4 2017 | 4.27% |
| Q3 2017 | -0.91% |
| Q2 2017 | -0.07% |
| Q1 2017 | 5.85% |
| Q4 2016 | 14.98% |
| Q3 2016 | -0.86% |
| Q2 2016 | 3.98% |
| Q1 2016 | 2.10% |